COMP <GO>
AWI vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Armstrong World Industries Inc (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: AWI 11
— TMO 4
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: AWI
LAST: $166.34 (+0.24%) • MKT CAP: $6.94B
balance-sheet
7.49
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AWI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AWI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.60% | 41.00% | -0.40 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.70% | 9.30% | +19.40 | AWI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.7x | 30.4x | -15.70 | AWI | /valuation <GO> |
| Free Cash Flow Yield | 4.07% | 2.40% | +1.67 | AWI | /fcf-yield <GO> |
| Operating Margin | 26.60% | 17.40% | +9.20 | AWI | /operating-margins <GO> |
| Net Profit Margin | 19.00% | 15.10% | +3.90 | AWI | /net-margins <GO> |
| Revenue Growth (YoY) | 12.10% | 3.90% | +8.20 | AWI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.80% | 0.24% | +0.56 | AWI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 7.49 | 4.50 | +2.99 | AWI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | AWI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.70% | +0.20 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.1 | 59.1 | -7.02 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.94 | +0.07 | AWI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.9x | 36.3x | -17.40 | AWI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.94B | $262.22B | -$255.28B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AWI REV | TMO REV | AWI GROSS % | TMO GROSS % | AWI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.62B | $44.56B | 40.6% | 44.0% | $282.6M | $6.29B |
| FY 2024 | $1.45B | $42.88B | 40.2% | 44.0% | $201.7M | $7.27B |
| FY 2023 | $1.30B | $42.86B | 44.0% | 44.0% | $175.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AWI // BETA 1.01
TMO // BETA 0.94